Neurocrine presents tardive dyskinesia treatment data at conference
Go back to Neurocrine presents tardive dyskinesia treatment data at conference| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 162.25 +0.63 (0.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $161.62 | 52 Week High | $58.46 | |||
| Open | $161.62 | 52 Week Low | $31.25 | |||
| Day High | $163.19 | P/E | N/A | |||
| Day Low | $161.57 | EPS | $-0.69 | |||
| Volume | 22,735 | |||||

